MRT vs. ZCAR, GETR, HYRE, UHAL, RDUS, KFRC, CTLP, PSFE, ECX, and GCT
Should you be buying MedEquities Realty Trust stock or one of its competitors? The main competitors of MedEquities Realty Trust include Zoomcar (ZCAR), Getaround (GETR), HyreCar (HYRE), U-Haul (UHAL), Radius Recycling (RDUS), Kforce (KFRC), Cantaloupe (CTLP), Paysafe (PSFE), ECARX (ECX), and GigaCloud Technology (GCT).
MedEquities Realty Trust vs. Its Competitors
MedEquities Realty Trust (NYSE:MRT) and Zoomcar (NASDAQ:ZCAR) are both small-cap automotive rental & leasing, without drivers industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.
20.7% of MedEquities Realty Trust shares are owned by institutional investors. Comparatively, 3.7% of Zoomcar shares are owned by institutional investors. 3.0% of MedEquities Realty Trust shares are owned by company insiders. Comparatively, 1.6% of Zoomcar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Zoomcar had 2 more articles in the media than MedEquities Realty Trust. MarketBeat recorded 2 mentions for Zoomcar and 0 mentions for MedEquities Realty Trust. Zoomcar's average media sentiment score of 0.78 beat MedEquities Realty Trust's score of 0.00 indicating that Zoomcar is being referred to more favorably in the news media.
MedEquities Realty Trust presently has a consensus target price of $5.19, indicating a potential upside of 82.34%. Given MedEquities Realty Trust's stronger consensus rating and higher probable upside, equities analysts clearly believe MedEquities Realty Trust is more favorable than Zoomcar.
MedEquities Realty Trust has a net margin of 0.00% compared to Zoomcar's net margin of -233.90%.
MedEquities Realty Trust has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, Zoomcar has a beta of -0.99, meaning that its stock price is 199% less volatile than the S&P 500.
MedEquities Realty Trust has higher revenue and earnings than Zoomcar.
Summary
MedEquities Realty Trust beats Zoomcar on 11 of the 13 factors compared between the two stocks.
Get MedEquities Realty Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for MRT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart
MedEquities Realty Trust Competitors List
Related Companies and Tools
This page (NYSE:MRT) was last updated on 7/10/2025 by MarketBeat.com Staff